Semaglutide studies: 1,194 papers with results
Page 5 of 24
- Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity.
Jensterle M · Diabetes, obesity & metabolism · 2023
Randomized controlled trial · 6 results
- Semaglutide, central retinal thickness and continuous glucose monitoring in persons with type 2 diabetes: A post-hoc analysis from a randomised trial.
Gullaksen S · Journal of diabetes and its complications · 2025
Randomized controlled trial · 3 results
- Semaglutide Improves Lipid Subfraction Profiles in Type 2 Diabetes: Insights from a One-Year Follow-Up Study.
Tóth LI · International journal of molecular sciences · 2025
Randomized controlled trial · 8 results
- Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes.
Gibbons C · Diabetes, obesity & metabolism · 2021
Randomized controlled trial · 9 results
- Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial.
Petković-Dabić J · Biomolecules · 2025
Randomized controlled trial · 6 results
- Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER.
Shaman AM · Circulation · 2022
Randomized controlled trial · 18 results
- Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes.
Heise T · Diabetes care · 2023
Randomized controlled trial · 9 results
- Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials.
Ahrén B · Diabetes, obesity & metabolism · 2018
Randomized controlled trial · 5 results
- Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials.
DeSouza C · The Journal of clinical endocrinology and metabolism · 2020
Randomized controlled trial · 9 results
- Metabolic effects of very-low calorie diet, Semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus.
Anyiam O · Clinical nutrition (Edinburgh, Scotland) · 2024
Randomized controlled trial · 15 results
- Semaglutide improves health-related quality of life versus placebo when added to standard of care in patients with type 2 diabetes at high cardiovascular risk (SUSTAIN 6).
Jódar E · Diabetes, obesity & metabolism · 2020
Randomized controlled trial · 5 results
- Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial.
Kushner RF · Obesity (Silver Spring, Md.) · 2025
Randomized controlled trial · 9 results
- Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test.
Mather KJ · The Journal of clinical endocrinology and metabolism · 2024
Randomized controlled trial · 16 results
- Efficacy and safety of once-weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass index.
Yabe D · Journal of diabetes investigation · 2022
Randomized controlled trial · 5 results
- Efficacy and safety of oral semaglutide by baseline age in Japanese patients with type 2 diabetes: A subgroup analysis of the PIONEER 9 and 10 Japan trials.
Yamada Y · Diabetes, obesity & metabolism · 2022
Randomized controlled trial · 4 results
- Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6.
Husain M · Cardiovascular diabetology · 2022
Randomized controlled trial · 4 results
- Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6.
Apperloo EM · Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
Randomized controlled trial · 3 results
- Effect of once-weekly subcutaneous semaglutide 2.4 mg on weight- and health-related quality of life in an East Asian population: Patient-reported outcomes from the STEP 6 trial.
Kolotkin RL · Clinical obesity · 2023
Randomized controlled trial · 10 results
- Effect of Orally Administered Semaglutide Versus Dulaglutide on Diabetes-Related Quality of Life in Japanese Patients with Type 2 Diabetes: The PIONEER 10 Randomized, Active-Controlled Trial.
Ishii H · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
Randomized controlled trial · 14 results
- Improved health-related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT-5 trial.
Shukla AP · Diabetes, obesity & metabolism · 2026
Randomized controlled trial · 12 results
- Effect of semaglutide versus placebo on cardiorenal outcomes by prior cardiovascular disease and baseline body mass index: Pooled post hoc analysis of SUSTAIN 6 and PIONEER 6.
Zhou J · Diabetes, obesity & metabolism · 2025
Randomized controlled trial · 8 results
- Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis.
Karakus KE · Diabetes care · 2026
Randomized controlled trial · 8 results
- Effect of once-weekly subcutaneous semaglutide on abdominal visceral fat area in Japanese adults with overweight and obesity: A post hoc analysis of the STEP 6 trial.
Kadowaki T · Obesity research & clinical practice · 2025
Randomized controlled trial · 9 results
- Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials.
Tchang BG · Obesity (Silver Spring, Md.) · 2025
Randomized controlled trial · 3 results
- Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial.
Meyhöfer SM · Nature medicine · 2026
Randomized controlled trial · 4 results
- The effects of semaglutide, empagliflozin and their combination on the kidney sodium signal from magnetic resonance imaging: A prespecified, secondary analysis from a randomized, clinical trial.
Gullaksen S · Journal of diabetes and its complications · 2024
Randomized controlled trial · 3 results
- The improved health utility of once-weekly subcutaneous semaglutide 2.4 mg compared with placebo in the STEP 1-4 obesity trials.
Bjorner JB · Diabetes, obesity & metabolism · 2023
Randomized controlled trial · 3 results
- Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial.
Rayner B · Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
Randomized controlled trial · 9 results
- Efficacy of CagriSema for Reaching Anthropometric Treatment Targets and Cardiometabolic Outcomes: A Secondary, Post hoc Analysis of REDEFINE 1.
Busetto L · Diabetes, obesity & metabolism · 2026
Randomized controlled trial · 6 results
- Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis.
Aronne LJ · The American journal of medicine · 2026
Randomized controlled trial · 12 results
- Effects of semaglutide and empagliflozin on markers of endothelial function in persons with type 2 diabetes: A post hoc analysis of a randomized clinical trial.
Gullaksen S · Journal of diabetes and its complications · 2026
Randomized controlled trial · 8 results
- Effect of Semaglutide on the Inflammatory Biomarker High-Sensitivity CRP in Patients With Established Cardiovascular Disease and Overweight or Obesity in SELECT: A Prespecified Secondary Analysis.
Plutzky J · Circulation · 2026
Randomized controlled trial · 6 results
- Semaglutide Treatment in Young Adults Living With Type 2 Diabetes: A Post Hoc Analysis From the SUSTAIN and PIONEER Clinical Trials.
Zaccardi F · Diabetes, obesity & metabolism · 2026
Randomized controlled trial · 3 results
- Efficacy of tirzepatide versus semaglutide in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial.
Neves JS · Diabetologia · 2026
Randomized controlled trial · 13 results
- Ocular Adverse Events With Semaglutide: A Systematic Review and Meta-Analysis.
Natividade GR · JAMA ophthalmology · 2025
Systematic review · 3 results
- The adverse effects associated with semaglutide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis.
Sillassen CDB · BMC medicine · 2025
Systematic review · 6 results
- Effects of semaglutide on mortality, cardiovascular, and kidney outcomes across the cardio-kidney-metabolic continuum: a systematic review and meta-analysis.
Marzano F · Cardiovascular diabetology · 2026
Systematic review · 7 results
- Semaglutide for the prevention of atrial fibrillation: A systematic review and meta-analysis.
Zhang HD · Diabetes & metabolic syndrome · 2024
Systematic review · 7 results
- Effects of oral semaglutide on cardiovascular outcomes: A systematic review and meta-analysis.
Rebelo TG · International journal of cardiology · 2025
Systematic review · 5 results
- Semaglutide and cancer: A systematic review and meta-analysis.
Nagendra L · Diabetes & metabolic syndrome · 2023
Systematic review · 7 results
- Safety and Efficacy of Semaglutide in Patients With Chronic Kidney Disease, With or Without Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Abdullah A · Endocrinology, diabetes & metabolism · 2025
Systematic review · 3 results
- Efficacy and safety of oral semaglutide in type 2 diabetes mellitus: A systematic review and meta-analysis.
Li A · Diabetes research and clinical practice · 2023
Systematic review · 7 results
- Semaglutide for the Silent Phenotype: A Translational Signal in Obesity-Driven HFpEF.
Ceravolo R · The American journal of cardiology · 2026
Systematic review · 3 results
- Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis.
Tan HC · Journal of the ASEAN Federation of Endocrine Societies · 2022
Systematic review · 5 results
- Effectiveness & safety of semaglutide in weight reduction in obese nondiabetic patients: A systematic review and meta-analysis.
Naz F · Medicine · 2026
Systematic review · 8 results
- Efficacy and safety of once-weekly semaglutide in adults with overweight or obesity: a meta-analysis.
Zhong P · Endocrine · 2022
Systematic review · 7 results
- Semaglutide and blood pressure: an individual patient data meta-analysis.
Kennedy C · European heart journal · 2024
Systematic review · 7 results
- Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Moiz A · The American journal of cardiology · 2024
Systematic review · 6 results
- Role of semaglutide in the treatment of nonalcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis.
Bandyopadhyay S · Diabetes & metabolic syndrome · 2023
Systematic review · 8 results
- Impact of semaglutide on biochemical and radiologic measures of metabolic-dysfunction associated fatty liver disease across the spectrum of glycaemia: A meta-analysis.
Dutta D · Diabetes & metabolic syndrome · 2022
Systematic review · 14 results